Antenatal corticosteroid treatment: factors other than lung maturation

References

• Goldenberg RL, Culhane JF, Iams JD, et al. Epidemiology and causes of preterm birth. Lancet 2008;371:75–84.
   PubMed Web of Science ®Google Scholar
• Beck S, Wojdyla D, Say L, et al. The worldwide incidence of preterm birth: a systematic review of maternal mortality and morbidity. Bull World Health Organ 2010;88:31–8.
   PubMed Web of Science ®Google Scholar
• Thompson JM, Irgens LM, Rasmussen S, et al. Secular trends in socio-economic status and the implications for preterm birth. Paediatr Perinat Epidemiol 2006;20:182–7.
   PubMed Web of Science ®Google Scholar
• Hamilton BE, Martin JA, Ventura SJ. Births: preliminary data for 2010. Natl Vital Stat Rep 2011;60:1–26.
   PubMedGoogle Scholar
• Ward RM, Beachy JC. Neonatal complications following preterm birth. BJOG 2003;110:8–16.
   PubMed Web of Science ®Google Scholar
• Talge NM, Holzman C, Wang J, et al. Late-preterm birth and its association with cognitive and socioemotional outcomes at 6 years of age. Pediatrics 2010;126:1124–31.
   PubMed Web of Science ®Google Scholar
• Baud O, Sola A. Corticosteroids in perinatal medicine: how to improve outcomes without affecting the developing brain? Semin Fetal Neonatal Med 2007;12:273–9.
   PubMed Web of Science ®Google Scholar
• Ballard PL, Ballard RA. Scientific basis and therapeutic regimens for use of antenatal glucocorticoids. Am J Obstet Gynecol 1995;173:254–62.
   PubMed Web of Science ®Google Scholar
• Walther FJ, David-Cu R, Mehta EI, et al. Higher lung antioxidant enzyme activity persists after single dose of corticosteroids in preterm lambs. Am J Physiol 1996;271:L187–91.
   Web of Science ®Google Scholar
• O’Shea TM, Doyle LW. Perinatal glucocorticoid therapy and neurodevelopmental outcome: an epidemiologic perspective. Semin Neonatol 2001;6:293–307.
   PubMedGoogle Scholar
• Jobe AH, Nitsos I, Pillow JJ, et al. Betamethasone dose and formulation for induced lung maturation in fetal sheep. Am J Obstet Gynecol 2009;201:611–17.
   PubMed Web of Science ®Google Scholar
• Samtani MN, Lohle M, Grant A, et al. Betamethasone pharmacokinetics after two prodrug formulations in sheep: implications for antenatal corticosteroid use. Drug Metab Dispos 2005;33:1124–30.
   PubMed Web of Science ®Google Scholar
• Brownfoot FC, Crowther CA, Middleton P. Different corticosteroids and regimens for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev 2008;CD006764.
   PubMed Web of Science ®Google Scholar
• Ballard PL, Granberg P, Ballard RA. Glucocorticoid levels in maternal and cord serum after prenatal betamethasone therapy to prevent respiratory distress syndrome. J Clin Invest 1975;56:1548–54.
   PubMed Web of Science ®Google Scholar
• Liggins GC, Howie RN. A controlled trial of antepartum glucocorticoid treatment for prevention of the respiratory distress syndrome in premature infants. Pediatrics 1972;50:515–25.
   PubMed Web of Science ®Google Scholar
• Roberts D, Dalziel S. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev 2006;(3):CD004454.
   PubMed Web of Science ®Google Scholar
• Wapner R, Jobe AH. Controversy: antenatal steroids. Clin Perinatol 2011;38:529–45.
   PubMed Web of Science ®Google Scholar
• Khandelwal M, Chang E, Hansen C, et al. Betamethasone dosing interval: 12 or 24 hours apart? A randomized, noninferiority open trial. Am J Obstet Gynecol 2012;206:201–11.
   PubMed Web of Science ®Google Scholar
• Romejko-Wolniewicz E, Teliga-Czajkowska J, Czajkowski K. Antenatal steroids: can we optimize the dose? Curr Opin Obstet Gynecol 2014;26:77–82.
   PubMed Web of Science ®Google Scholar
• Asztalos EV, Murphy KE, Willan AR, et al. Multiple courses of antenatal corticosteroids for preterm birth study: outcomes in children at 5 years of age (MACS-5). JAMA Pediatr 2013;167:1102–10.
   PubMed Web of Science ®Google Scholar
• Bonanno C, Wapner RJ. Antenatal corticosteroids in the management of preterm birth: are we back where we started? Obstet Gynecol Clin North Am 2012;39:47–63.
   PubMed Web of Science ®Google Scholar
• Vis JY, Wilms FF, Kuin RA, et al. Time to delivery after the first course of antenatal corticosteroids: a cohort study. Am J Perinatol 2011;28:683–8.
   PubMed Web of Science ®Google Scholar
• Wilms FF, Vis JY, Pattinaja DA, et al. Relationship between the time interval from antenatal corticosteroid administration until preterm birth and the occurrence of respiratory morbidity. Am J Obstet Gynecol 2011;205:49–7.
   PubMed Web of Science ®Google Scholar
• Ring AM, Garland JS, Stafeil BR, et al. The effect of a prolonged time interval between antenatal corticosteroid administration and delivery on outcomes in preterm neonates: a cohort study. Am J Obstet Gynecol 2007;196:457.e1–6.
   PubMed Web of Science ®Google Scholar
• Crowther CA, Haslam RR, Hiller JE, et al. Neonatal respiratory distress syndrome after repeat exposure to antenatal corticosteroids: a randomised controlled trial. Lancet 2006;367:1913–19.
   PubMed Web of Science ®Google Scholar
• Wapner RJ, Sorokin Y, Thom EA, et al. Single versus weekly courses of antenatal corticosteroids: evaluation of safety and efficacy. Am J Obstet Gynecol 2006;195:633–42.
   PubMed Web of Science ®Google Scholar
• Murphy KE, Hannah ME, Willan AR, et al. Multiple courses of antenatal corticosteroids for preterm birth (MACS): a randomised controlled trial. Lancet 2008;372:2143–51.
   PubMed Web of Science ®Google Scholar
• Garite TJ, Kurtzman J, Maurel K, et al. Impact of a ‘rescue course’ of antenatal corticosteroids: a multicenter randomized placebo-controlled trial. Am J Obstet Gynecol 2009;200:248–9.
   PubMed Web of Science ®Google Scholar
• McKinlay CJ, Crowther CA, Middleton P, et al. Repeat antenatal glucocorticoids for women at risk of preterm birth: a Cochrane systematic review. Am J Obstet Gynecol 2012;206:187–94.
   PubMed Web of Science ®Google Scholar
• Royal College of Obstetricians and Gynaecologists. Chapter Green top Guideline no 7. London: Royal College of Obstetricians and Gynaecologists; 2010.
   Google Scholar
• Wright LL, Verter J, Younes N, et al. Antenatal corticosteroid administration and neonatal outcome in very low birth weight infants: the NICHD Neonatal Research Network. Am J Obstet Gynecol 1995;173:269–74.
   PubMed Web of Science ®Google Scholar
• Magee LA, Dawes GS, Moulden M, et al. A randomised controlled comparison of betamethasone with dexamethasone: effects on the antenatal fetal heart rate. Br J Obstet Gynaecol 1997;104:1233–8.
   PubMedGoogle Scholar
• Mulder EJ, Derks JB, Zonneveld MF, et al. Transient reduction in fetal activity and heart rate variation after maternal betamethasone administration. Early Hum Dev 1994;36:49–60.
   PubMed Web of Science ®Google Scholar
• Rotmensch S, Liberati M, Celentano C, et al. The effect of betamethasone on fetal biophysical activities and Doppler velocimetry of umbilical and middle cerebral arteries. Acta Obstet Gynecol Scand 1999;78:768–73.
   PubMed Web of Science ®Google Scholar
• Wijnberger LD, Bilardo CM, Hecher K, et al. Effect of antenatal glucocorticoid therapy on arterial and venous blood flow velocity waveforms in severely growth-restricted fetuses. Ultrasound Obstet.Gynecol 2004;23:584–9.
   PubMed Web of Science ®Google Scholar
• Wapner RJ. Antenatal corticosteroids for periviable birth. Semin Perinatol 2013;37:410–13.
   PubMed Web of Science ®Google Scholar
• Porto AM, Coutinho IC, Correia JB, et al. Effectiveness of antenatal corticosteroids in reducing respiratory disorders in late preterm infants: randomised clinical trial. BMJ 2011;342:d1696.
   PubMed Web of Science ®Google Scholar
• Sifianou P, Thanou V, Karga H. Metabolic and hormonal effects of antenatal betamethasone after 35 weeks of gestation. J Pediatr Pharmacol Ther 2015;20:138–43.
   PubMedGoogle Scholar
• Ahmad I, Beharry KD, Valencia AM, et al. Influence of a single course of antenatal betamethasone on the maternal–fetal insulin–IGF–GH axis in singleton pregnancies. Growth Horm IGF Res 2006;16:267–75.
   PubMed Web of Science ®Google Scholar
• Royal College of Obstetricians and Gynaecologists. RCOG Green-top Guideline No. 7. London: Royal College of Obstetricians and Gynaecologists; 2004.
   Google Scholar
• Kamath-Rayne BD, Defranco EA, Marcotte MP. Antenatal steroids for treatment of fetal lung immaturity after 34 weeks of gestation: an evaluation of neonatal outcomes. Obstet Gynecol 2012;119:909–16.
   PubMed Web of Science ®Google Scholar
• Bloom SL, Sheffield JS, McIntire DD, et al. Antenatal dexamethasone and decreased birth weight. Obstet Gynecol 2001;97:485–90.
   PubMed Web of Science ®Google Scholar
• Banks BA, Cnaan A, Morgan MA, et al. Multiple courses of antenatal corticosteroids and outcome of premature neonates. North American Thyrotropin-Releasing Hormone Study Group. Am J Obstet Gynecol 1999;181:709–17.
   PubMed Web of Science ®Google Scholar
• Wang KG, Chen CY, Chen YY. The effects of absent or reversed end-diastolic umbilical artery Doppler flow velocity. Taiwan J Obstet Gynecol 2009;48:225–31.
   PubMed Web of Science ®Google Scholar
• Marconi AM, Cetin I, Ferrazzi E, et al. Lactate metabolism in normal and growth-retarded human fetuses. Pediatr Res 1990;28:652–6.
   PubMed Web of Science ®Google Scholar
• Nicolaides KH, Bilardo CM, Soothill PW, et al. Absence of end diastolic frequencies in umbilical artery: a sign of fetal hypoxia and acidosis. BMJ 1988;297:1026–7.
   PubMed Web of Science ®Google Scholar
• Soothill PW, Nicolaides KH, Bilardo K, et al. Utero-placental blood velocity resistance index and umbilical venous pO2, pCO2, pH, lactate and erythroblast count in growth-retarded fetuses. Fetal Ther 1986;1:176–9.
   PubMedGoogle Scholar
• du Plessis JM, Hall DR, Norman K, et al. Reversed end diastolic flow velocity in viable fetuses: is there time to wait for the effect of corticosteroids before delivery? Int J Gynaecol Obstet 2001;72:187–8.
   PubMed Web of Science ®Google Scholar
• Simchen MJ, Alkazaleh F, Adamson SL, et al. The fetal cardiovascular response to antenatal steroids in severe early-onset intrauterine growth restriction. Am J Obstet Gynecol 2004;190:296–304.
   PubMed Web of Science ®Google Scholar
• Wallace EM, Baker LS. Effect of antenatal betamethasone administration on placental vascular resistance. Lancet 1999;353:1404–7.
   PubMed Web of Science ®Google Scholar
• Dalziel SR, Liang A, Parag V, et al. Blood pressure at 6 years of age after prenatal exposure to betamethasone: follow-up results of a randomized, controlled trial. Pediatrics 2004;114:e373–7.
   Google Scholar
• Alexander N, Rosenlocher F, Stalder T, et al. Impact of antenatal synthetic glucocorticoid exposure on endocrine stress reactivity in term-born children. J Clin Endocrinol Metab 2012;97:3538–44.
   PubMed Web of Science ®Google Scholar
• Dalziel SR, Lim VK, Lambert A, et al. Antenatal exposure to betamethasone: psychological functioning and health related quality of life 31 years after inclusion in randomised controlled trial. BMJ 2005;331:665.
   PubMed Web of Science ®Google Scholar
• Crowther CA, Doyle LW, Haslam RR, et al. Outcomes at 2 years of age after repeat doses of antenatal corticosteroids. N Engl J Med 2007;357:1179–89.
   PubMed Web of Science ®Google Scholar
• Wapner RJ, Sorokin Y, Mele L, et al. Long-term outcomes after repeat doses of antenatal corticosteroids. N Engl J Med 2007;357:1190–8.
   PubMed Web of Science ®Google Scholar